Volume 60, Issue 6, Pages (June 2014)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Sepsis in alcohol-related liver disease
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 62, Issue 4, Pages (April 2015)
Primary prevention of variceal haemorrhage: A pharmacological approach
Volume 61, Issue 6, Pages (December 2014)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
The gut microbiota and the liver
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute- on-chronic liver failure  Manuel Romero-Gómez, Sara Montagnese, Rajiv.
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Human serum albumin, systemic inflammation, and cirrhosis
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Volume 144, Issue 7, Pages e9 (June 2013)
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Inflammation and portal hypertension – The undiscovered country
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Volume 64, Issue 3, Pages (March 2016)
Acute-on chronic liver failure
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Volume 69, Issue 2, Pages (August 2018)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
The heart in liver transplantation
The changing role of beta-blocker therapy in patients with cirrhosis
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 60, Issue 6, Pages (June 2014)
Volume 53, Issue 6, Pages (December 2010)
Volume 150, Issue 7, Pages (June 2016)
Volume 50, Issue 4, Pages (April 2009)
Volume 41, Issue 3, Pages (September 2004)
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?  Jingzhi Cai, Wengang Guo, Chuangye.
Volume 66, Issue 5, Pages (May 2017)
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 44, Issue 1, Pages (January 2006)
MELD: the holy grail of organ allocation?
Volume 157, Issue 1, Pages (July 2019)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Sepsis in alcohol-related liver disease
Presentation transcript:

Volume 60, Issue 6, Pages 1310-1324 (June 2014) Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013  Rajiv Jalan, Javier Fernandez, Reiner Wiest, Bernd Schnabl, Richard Moreau, Paolo Angeli, Vanessa Stadlbauer, Thierry Gustot, Mauro Bernardi, Rafael Canton, Agustin Albillos, Frank Lammert, Alexander Wilmer, Rajeshwar Mookerjee, Jordi Vila, Rita Garcia-Martinez, Julia Wendon, José Such, Juan Cordoba, Arun Sanyal, Guadalupe Garcia-Tsao, Vicente Arroyo, Andrew Burroughs, Pere Ginès  Journal of Hepatology  Volume 60, Issue 6, Pages 1310-1324 (June 2014) DOI: 10.1016/j.jhep.2014.01.024 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Mortality rate caused by bacterial infections in cirrhosis in the last decades. 1-month and 1-year mortality rates were higher before than after 2000, although differences were not statistically significant. Modified from [6]. Journal of Hepatology 2014 60, 1310-1324DOI: (10.1016/j.jhep.2014.01.024) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Pathogenesis of bacterial infections in cirrhosis. The risk of bacterial infection in cirrhosis is due to multiple factors that include liver dysfunction, portosystemic shunting, gut dysbiosis, increased bacterial translocation, cirrhosis-associated immune dysfunction (AID) and genetic factors. Journal of Hepatology 2014 60, 1310-1324DOI: (10.1016/j.jhep.2014.01.024) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Pathophysiological basis of acute on chronic liver failure and end-organ dysfunction in cirrhosis precipitated by infection. Journal of Hepatology 2014 60, 1310-1324DOI: (10.1016/j.jhep.2014.01.024) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 1310-1324DOI: (10. 1016/j. jhep. 2014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions